1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2.Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: a cancer journal for clinicians. 2018;68(1):31–54.
3.Castro C, Peleteiro B, Lunet N. Modifiable factors and esophageal cancer: a systematic review of published meta-analyses. J Gasteroenterol. 2018;53(1):37–51.
4.Fahey PP, Mallitt K-A, Astell-Burt T, Stone G, Whiteman DC. Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis. Cancer Causes Control. 2015;26(10):1365–73.
5.Toohey K, Pumpa K, Cooke J, Semple S. Do activity patterns and body weight change after a cancer diagnosis? a retrospective cohort study. Int J Health Sci Res. 2016;6(10):110–7.
6.Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814.
7.Rock CL, Doyle C, Demark‐Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):242–74.
8.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
9.Smithers BM, Fahey PP, Corish T, Gotley DC, Falk GL, Smith GS, et al. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro‐oesophageal junction in Australia. Med J Aust. 2010;193(10):572–7.
10.Morris LJ, D’Este C, Sargent-Cox K, Anstey KJ. Concurrent lifestyle risk factors: Clusters and determinants in an Australian sample. Prev Med. 2016;84:1–5.
11.Surveillance, Epidemiology, and End Results (SEER) Program. Research Data (1973–2013). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission.
12.Centers for Disease Control and Prevention (CDA). Behavioral Risk Factor Surveillance System Survey Data. U.S. Department of Health and Human Servies, Centers for Disease Control and Prevention. Atlanta, Georgia. 2001–2014.
13.Jamal A. Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2016;65.
14.Gilman SE, Breslau J, Conron KJ, Koenen KC, Subramanian S, Zaslavsky A. Education and race-ethnicity differences in the lifetime risk of alcohol dependence. J Epidemiol Community Health. 2008;62(3):224–30.
15.Lauder W, Mummery K, Jones M, Caperchione C. A comparison of health behaviours in lonely and non-lonely populations. Psychol Health Med. 2006;11(2):233–45.
16.Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59(01):39–48.
17.Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, et al. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. 2012;131(5):E759-E68.
18.Thrift AP, Nagle CM, Fahey PP, Smithers BM, Watson DI, Whiteman DC. Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control. 2012;23(4):555–64.
19.Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–6.
20.Kuang J-j, Jiang Z-m, Chen Y-x, Ye W-p, Yang Q, Wang H-z, et al. Smoking exposure and survival of patients with esophagus cancer: a systematic review and meta-analysis. Gastroenterol Research Pract. 2016;2016.
21.Ma Q, Liu W, Jia R, Long H, Zhang L, Lin P, et al. Alcohol and survival in ESCC: Prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients. Oncotarget. 2016;7(25):38857.
22.Sun P, Zhang F, Chen C, Ren C, Bi X-W, Yang H, et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2016;9:6389.
23.Spreafico A, Coate L, Zhai R, Xu W, Chen Z-F, Chen Z, et al. Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival. Cancer Epidemiol. 2017;47:28–34.
24.Okada E, Ukawa S, Nakamura K, Hirata M, Nagai A, Matsuda K, et al. Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project. J Epidemiol. 2017;27(Supplement_III):S29-S35.
25.Dandara C, Robertson B, Dzobo K, Moodley L, Parker MI. Patient and tumour characteristics as prognostic markers for oesophageal cancer: a retrospective analysis of a cohort of patients at Groote Schuur Hospital. Eur J Cardiothorac Surg. 2015;49(2):629–34.
26.Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev Nutr. 2012;32:311–42.
27.Reichle K, Peter RS, Concin H, Nagel G. Associations of pre-diagnostic body mass index with overall and cancer-specific mortality in a large Austrian cohort. Cancer Causes Control. 2015;26(11):1643–52.
28.Lynch BM, Leitzmann MF. An evaluation of the evidence relating to physical inactivity, sedentary behavior, and cancer incidence and mortality. Curr Epidemiol Rep. 2017;4(3):221–31.
29.Schneider KL, Clark MA, Rakowski W, Lapane KL. Evaluating the impact of non-response bias in the Behavioral Risk Factor Surveillance System (BRFSS). J Epidemiol Community Health. 2012;66(4):290–5.